{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,6]],"date-time":"2026-03-06T16:39:36Z","timestamp":1772815176765,"version":"3.50.1"},"reference-count":17,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2008,1,1]],"date-time":"2008-01-01T00:00:00Z","timestamp":1199145600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2014,11,29]],"date-time":"2014-11-29T00:00:00Z","timestamp":1417219200000},"content-version":"vor","delay-in-days":2524,"URL":"https:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Clinical Microbiology and Infection"],"published-print":{"date-parts":[[2008,1]]},"DOI":"10.1111\/j.1469-0691.2007.01856.x","type":"journal-article","created":{"date-parts":[[2008,2,8]],"date-time":"2008-02-08T12:29:04Z","timestamp":1202473744000},"page":"169-174","source":"Crossref","is-referenced-by-count":72,"special_numbering":"S1","title":["Breakpoints for intravenously used cephalosporins in Enterobacteriaceae\u2014EUCAST and CLSI breakpoints"],"prefix":"10.1016","volume":"14","author":[{"given":"G.","family":"Kahlmeter","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1111\/j.1469-0691.2007.01856.x_bib1","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1093\/jac\/dkg312","article-title":"European harmonisation of MIC breakpoints for antimicrobial susceptibility testing of bacteria","volume":"52","author":"Kahlmeter","year":"2003","journal-title":"J Antimicrob Chemother"},{"key":"10.1111\/j.1469-0691.2007.01856.x_bib2","series-title":"Methods for dilution antimicrobial susceptibility tests for bacteria that grow aerobically","author":"National Committee for Clinical Laboratory Standards","year":"2000"},{"issue":"suppl 1","key":"10.1111\/j.1469-0691.2007.01856.x_bib3","first-page":"S11","article-title":"Technical recommendations for in vitro susceptibility testing","volume":"2","author":"Comit\u00e9 de l'Antibiogramme de la Soci\u00e9t\u00e9 Fran\u00e7aise de Microbiologie","year":"1996","journal-title":"Clin Microbiol Infect"},{"key":"10.1111\/j.1469-0691.2007.01856.x_bib4","series-title":"Medical microbiology\u2013susceptibility testing of pathogens to antimicrobial agents","author":"Deutsches Institut f\u00fcr Normung","year":"1999"},{"key":"10.1111\/j.1469-0691.2007.01856.x_bib5","first-page":"79","article-title":"Interpretatie van gevoeligheidsonderzoek en gevoeligheidscriteria voor antibacteri\u00eble middelen in Nederland","volume":"3","author":"Commissie Richtlijnen Gevoeligheidsbepalingen","year":"2000","journal-title":"Nederlands Tijdschrift Med Microbiol"},{"issue":"suppl","key":"10.1111\/j.1469-0691.2007.01856.x_bib6","first-page":"1","article-title":"Susceptibility testing of bacteria and fungi","volume":"103","author":"Bergan","year":"1997","journal-title":"Scand J Infect Dis"},{"key":"10.1111\/j.1469-0691.2007.01856.x_bib7","first-page":"5","article-title":"Antimicrobial susceptibility testing in Sweden","volume":"105","author":"The Swedish Reference Group of Antibiotics","year":"1997","journal-title":"Scand J Infect Dis Suppl"},{"issue":"suppl S1","key":"10.1111\/j.1469-0691.2007.01856.x_bib8","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1093\/jac\/48.suppl_1.17","article-title":"Establishing MIC breakpoints and interpretation of in vitro susceptibility tests","volume":"48","author":"MacGowan","year":"2001","journal-title":"J Antimicrob Chemother"},{"key":"10.1111\/j.1469-0691.2007.01856.x_bib10","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1086\/324742","article-title":"Molecular correlation for the treatment outcomes in blood stream infections caused by Escherichia coli and Klebsiella pneumoniae","volume":"34","author":"Wong-Beringer","year":"2002","journal-title":"Clin Infect Dis"},{"key":"10.1111\/j.1469-0691.2007.01856.x_bib11","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1086\/420816","article-title":"Antibiotic therapy for Klebsiella penumoniae bacteremia implications of production of extended spectrum beta-lactamases","volume":"39","author":"Paterson","year":"2004","journal-title":"Clin Infect Dis"},{"issue":"suppl 1","key":"10.1111\/j.1469-0691.2007.01856.x_bib12","doi-asserted-by":"crossref","first-page":"S20","DOI":"10.1016\/j.amjmed.2006.03.013","article-title":"Resistance in Gram-negative bacteria: Enterobacteriaceae","volume":"119","author":"Paterson","year":"2006","journal-title":"Am J Med"},{"key":"10.1111\/j.1469-0691.2007.01856.x_bib13","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1016\/j.diagmicrobio.2005.09.011","article-title":"Outcomes evaluation of patients with ESBL- and non-ESBL-producing Escherichia coli and Klebsiella species as defined by CLSI reference methods: report from the SENTRY Antimicrobial Surveillance Program","volume":"54","author":"Bhavnani","year":"2006","journal-title":"Diagn Microbiol Infect Dis"},{"key":"10.1111\/j.1469-0691.2007.01856.x_bib14","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1093\/jac\/dkl483","article-title":"CTX-M: changing the face of ESBLs in Europe","volume":"59","author":"Livermore","year":"2007","journal-title":"J Antimicrob Chemother"},{"issue":"suppl 6","key":"10.1111\/j.1469-0691.2007.01856.x_bib15","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1111\/j.1469-0691.2005.01265.x","article-title":"Treatment of infections with ESBL-producing organisms: pharmacokinetic and pharmacodynamic considerations","volume":"11","author":"Andes","year":"2005","journal-title":"Clin Microbiol Infect"},{"key":"10.1111\/j.1469-0691.2007.01856.x_bib16","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1016\/j.diagmicrobio.2005.02.006","article-title":"Reevaluation of Enterobacteriaceae MIC\/disk diffusion zone diameter regression scattergrams for 9 beta-lactams: adjustments of breakpoints for strains producing ESBLs","volume":"52","author":"Jones","year":"2005","journal-title":"Diagn Microbiol Infect Dis"},{"key":"10.1111\/j.1469-0691.2007.01856.x_bib17","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1093\/jac\/dkl431","article-title":"Efficacy of practised screening methods for detection of cephalosporine resistant Enterobacteriaceae","volume":"59","author":"Hope","year":"2007","journal-title":"J Antimicrob Chemother"},{"key":"10.1111\/j.1469-0691.2007.01856.x_bib18","doi-asserted-by":"crossref","first-page":"1971","DOI":"10.1128\/JCM.00062-06","article-title":"Identification of extended-spectrum, AmpC, and carbapenem hydrolyzing beta-lactamases in Escherichia coli and Klebsiella pneumoniae by disk test","volume":"44","author":"Jacoby","year":"2006","journal-title":"J Clin Microbiol"}],"container-title":["Clinical Microbiology and Infection"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1198743X14604894?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1198743X14604894?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,5,7]],"date-time":"2019-05-07T19:46:24Z","timestamp":1557258384000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1198743X14604894"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,1]]},"references-count":17,"alternative-id":["S1198743X14604894"],"URL":"https:\/\/doi.org\/10.1111\/j.1469-0691.2007.01856.x","relation":{},"ISSN":["1198-743X"],"issn-type":[{"value":"1198-743X","type":"print"}],"subject":[],"published":{"date-parts":[[2008,1]]}}}